Transplant glomerulopathy: subclinical incidence and association with alloantibody.
about
The importance of C4d in biopsies of kidney transplant recipientsEffector mechanisms of rejectionAn analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.Results of gal-knockout porcine thymokidney xenografts.Renal transplantation in patients with hepatitis C virus antibody. A long national experience.Probabilistic (Bayesian) modeling of gene expression in transplant glomerulopathyPreexisting donor-specific HLA antibodies predict outcome in kidney transplantationPicking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluationDiminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathyDiagnosis and management of antibody-mediated rejection: current status and novel approaches.Quantifying renal allograft loss following early antibody-mediated rejection.Antibodies reactive to non-HLA antigens in transplant glomerulopathyExperimental glomerular endothelial injury in vivoEmerging role of B cells in chronic allograft dysfunction.Late kidney allograft loss: what we know about it, and what we can do about itThe two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspectiveInterpreting Anti-HLA Antibody Testing Data: A Practical Guide for PhysiciansAntibody-mediated rejection of single class I MHC-disparate cardiac allografts.The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.Chronic alloantibody mediated rejection.Transplant glomerulopathy.The spectrum of antibody-mediated renal allograft injury: implications for treatment.The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure.Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeysIdentification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function.Antibody-Mediated Rejection: A Review.Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection.Chronic viral hepatitis in kidney transplantation.Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.Current problems of chronic active antibody-mediated rejection.Surveillance biopsies in children post-kidney transplant.Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice.Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.Phenotypes of antibody-mediated rejection in organ transplants.
P2860
Q27021227-71471E0E-15BA-44A0-A063-821B2A348080Q27027082-30FB8389-22B3-47B5-9FB9-D7489EF3204EQ33414342-495FBA28-C2E7-4097-BA7F-F65C4D9E2CC3Q33426548-EE0FB0E9-997D-4E3F-9BA0-DB0ACA9AA8D7Q33571091-FC2C12CE-7B15-4A45-88D1-4311177FFC5BQ33871282-1E9FC1E3-BD9D-488B-8715-EBC6D799F484Q34084853-ECA402C1-C180-45B2-957C-B9F89E1AD90DQ34124202-7F50B252-BD85-4264-8B58-1160CE04FB03Q34423734-14BA593A-4316-4399-94E1-693E9B869B3EQ34839515-8FDD1D00-936B-4E64-95D3-B9041A60931AQ34841849-1A414F59-5030-4115-9045-11361B0EA03BQ35007419-A18DA175-8276-4E90-ABF1-446973E6C865Q35012455-525818BC-AA85-4794-8C4B-AEE7030AE4C0Q35021857-D4AAC496-1397-4814-AD27-2B638080FF86Q35124576-30DB6223-104F-4987-B157-72D5390F50BDQ35153318-F033D506-1626-45CA-9491-25A71978EBB5Q35658590-18D4AC9D-0D8C-4872-AF98-93F93122EF34Q36007256-87FEDD64-FA57-409A-AB3C-ABA7474D0BACQ36131185-8BB2BB6E-0D67-40CF-9300-CA6D930E5346Q36240178-446CEF17-8E31-41FA-A018-768878A28E2FQ36677655-1AFC016F-28E3-46CB-BFD7-7F77CACB2751Q37042154-0CD5A680-E5A1-478A-9777-933D16DDF599Q37058039-8BCBF1EF-5339-49AD-9493-C67C3FBD8E94Q37058050-CFF1AC04-57F6-4B2C-B493-BC0F1263A574Q37092282-121D099F-4EB9-4C9A-B541-41F4B9C55ABFQ37176570-3512DB41-B842-44F0-8FEC-3E356CA9FC14Q37359074-88297E6A-9453-4C14-ADC6-3AABB8578BC1Q37367683-4D015EEE-97D4-4F29-9A2C-84C68D68F85BQ37485481-D0498387-38AB-4F57-B206-7B4EAD2216DEQ37535280-CDAF8A89-845F-4ACB-ABB2-625742B8020DQ37698860-996149DD-0965-4F0C-BC55-7C5DEEA263A1Q37704862-03A3603A-4653-4EC4-959A-1F5BBBA04975Q37833898-23EB1F28-548A-4DAE-9E1E-B1A47E50064DQ37859066-B699EFD9-EFCD-4EA5-B2F1-56577D0F4AD5Q37882017-32AA80C7-228E-46B8-95A5-803E663BC49DQ37906368-45B56A12-D3D9-4178-B150-BEB6C43E4DB8Q37907391-232312E1-EE89-4B2F-818B-43B01CC3830EQ37990988-C9E77E8B-98CC-4615-9482-522D00D8A333Q38003049-202F88A5-71CD-4327-8FCA-72282FE56F65Q38005448-BE0BFCF5-513F-4668-AC29-322099A519B4
P2860
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@en
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@nl
type
label
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@en
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@nl
prefLabel
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@en
Transplant glomerulopathy: subclinical incidence and association with alloantibody.
@nl
P2093
P2860
P1476
Transplant glomerulopathy: subclinical incidence and association with alloantibody
@en
P2093
Stegall MD
P2860
P304
P356
10.1111/J.1600-6143.2007.01895.X
P407
P577
2007-07-03T00:00:00Z